Dow’s Dastardly Deeds
By Staff of Organic Consumers Association - With Monsanto looking to be acquired by Germany-based Bayer, is Dow Chemical taking over Monsanto’s role of chief influence-buyer in Washington, D.C.? Dow wasted no time wooing Trump—the poison-peddler ponied up $1 million for the new president’s inauguration festivities. Trump swiftly rewarded Dow by naming CEO Andrew Liveris to head a new White House manufacturing working group. In February, after Trump signed an executive order aimed at rolling back regulations (including those on pesticides and GMOs), he handed the pen to Liveris. Fitting, given that Trump’s new EPA chief, Scott Pruitt, was quick to overturn the Obama administration’s proposed ban on one of Dow’s moneymakers, chlorpyrifos, an organophosphate pesticide. (Pruitt’s move prompted a lawsuit by environmental groups). Now, it seems, just banning organophosphates isn’t enough. A new report by the Associated Press (AP) says lawyers for Dow and two other manufacturers of organophosphates are asking Trump’s administration to throw out the EPA’s own studies on the dangerous effects of chlorpyrifos and other organophosphates, known to lower I.Q.s and cause neurological damage in children.